Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Advanced Cosmetic Intervention
A Multi-center Long Term Efficacy Trial of GFX for the Reduction of Glabellar Furrowing
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Has no medical contraindication
Presents for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Class 1 or Higher)
Is at least 18 years of age
Signs a written informed consent
Understands and accepts the obligation to present for scheduled follow-up visits
Understands that the GFX procedure may not be successful
Presents at the one month follow-up visit with an improvement from the base line RNKLS score
You may not be if
Has had an injection of botulinum toxin to the target area within the previous 4 months and still exhibits a positive cosmetic effect to the glabellar frown.
Has had silicone, fat, collagen or a synthetic material placed in the glabellar region or surgical correction or excision of the glabellar furrows
Has a known bleeding disorder
Pregnant
Has received or is anticipated to receive anti-platelets, anti-coagulants, thrombolytics, or cancer therapy
Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled or nasal corticosteroids are acceptable)
Has a history of chronic or recurrent infection or compromised immune system
Has severe allergies manifested by a history of anaphylaxis
Has known lidocaine hypersensitivity
Is enrolled in another study
Has history of keloid formation
The investigator believes the patient is not a suitable candidate for the GFX procedure, or is not likely to receive cosmetic benefitPresents at the one month follow-up visit with no improvement from the base line RNKLS score
Clareo Health | A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing
